Article Details

AstraZeneca Beats Mylan Challenge To Inhaler IP's Validity

Retrieved on: 2021-03-04 00:33:45

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca Beats Mylan Challenge To Inhaler IP's Validity. View article details on hiswai:

Excerpt

U.S. District Judge Irene M. Keeley ruled that Mylan fell short of being able to show that claims in the three AstraZeneca patents at issue were too ...

Article found on: www.law360.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up